Leo Pharma A/S, headquartered in Denmark (DK), is a prominent player in the pharmaceutical preparation manufacturing industry. Founded in 1908, the company has established itself as a leader in dermatology and critical care, focusing on innovative treatments for skin diseases and conditions. With a strong presence in Europe, North America, and Asia, Leo Pharma is dedicated to improving patients' lives through its specialised products.
The company’s core offerings include advanced therapies for psoriasis, eczema, and skin cancer, distinguished by their efficacy and commitment to patient care. Leo Pharma's dedication to research and development has led to significant milestones, including the launch of groundbreaking treatments that have reshaped the landscape of dermatological care. Recognised for its contributions to the industry, Leo Pharma continues to solidify its market position as a trusted provider of high-quality pharmaceutical solutions.
+55 vs industry average
Leo Pharma’s score of 93 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Leo Pharma?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2028
Reported emissions
Scope 3 accounts for ••• of total emissions.
Leo Pharma's reported carbon emissions
LEO Pharma, a pharmaceutical preparation manufacturer headquartered in DK, is committed to significant greenhouse gas emission reductions. In 2025, the company reported total emissions of approximately 242.5 million kg CO2e, comprising about 21.4 million kg CO2e in Scope 1, approximately 0.4 million kg CO2e in Scope 2 (market-based), and roughly 220.7 million kg CO2e in Scope 3. Key reduction targets include a commitment to reduce absolute Scope 1 and 2 GHG emissions by 53% by 2030 from a 2019 base year. LEO Pharma also aims for 75% of its suppliers by emissions to have science-based targets by 2026. Further long-term commitments include achieving net-zero greenhouse gas emissions across the value chain by 2050. More recently, as of the 2024 reporting year, LEO Pharma A/S has set new targets: reducing absolute Scope 1 and 2 GHG emissions by 63% by 2035 from a 2024 base year, and reducing absolute Scope 3 GHG emissions by 37.5% within the same timeframe. Their long-term ambition extends to reducing Scope 1, 2, and 3 GHG emissions by 90% by 2050 from a 2024 base year. The emissions data provided is directly reported by LEO Pharma A/S.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Leo Pharma’s Climate Goals (2030 & 2050)
1 goal2030
50% reduction in all scopes
Reduce our carbon emissions by more than 50% from 2019 to 2030
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 1 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
10 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives

Science Based Targets Initiative

Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsFrequently asked questions
Common questions about Leo Pharma’s sustainability data and climate commitments
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project